Norges Bank’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89M | Buy |
+835,874
| New | +$2.89M | ﹤0.01% | 1384 |
|
|
2025
Q1 | – | Sell |
-5,781,878
| Closed | -$23.8M | – | 1316 |
|
|
2024
Q4 | $23.8M | Buy |
+5,781,878
| New | +$23.8M | ﹤0.01% | 1202 |
|
|
2024
Q3 | – | Sell |
-3,319,342
| Closed | -$21.6M | – | 1379 |
|
|
2024
Q2 | $21.6M | Sell |
3,319,342
-73,283
| -2% | -$478K | ﹤0.01% | 1199 |
|
|
2024
Q1 | $28.2M | Buy |
3,392,625
+323,652
| +11% | +$2.69M | ﹤0.01% | 1167 |
|
|
2023
Q4 | $33.8M | Buy |
3,068,973
+1,562,145
| +104% | +$17.2M | 0.01% | 1087 |
|
|
2023
Q3 | $12.7M | Sell |
1,506,828
-106,956
| -7% | -$900K | ﹤0.01% | 1383 |
|
|
2023
Q2 | $20.3M | Hold |
1,613,784
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q1 | $26.6M | Sell |
1,613,784
-174,539
| -10% | -$2.87M | 0.01% | 1137 |
|
|
2022
Q4 | $26.7M | Buy |
1,788,323
+57,636
| +3% | +$861K | 0.01% | 1130 |
|
|
2022
Q3 | $38.7M | Buy |
1,730,687
+313,499
| +22% | +$7.01M | 0.01% | 880 |
|
|
2022
Q2 | $23.7M | Buy |
1,417,188
+479,262
| +51% | +$8.03M | 0.01% | 1159 |
|
|
2022
Q1 | $28.1M | Buy |
937,926
+117,926
| +14% | +$3.53M | 0.01% | 1206 |
|
|
2021
Q4 | $25.2M | Buy |
820,000
+322,235
| +65% | +$9.9M | 0.01% | 1347 |
|
|
2021
Q3 | $15.7M | Buy |
497,765
+267,135
| +116% | +$8.42M | ﹤0.01% | 1609 |
|
|
2021
Q2 | $8.44M | Buy |
230,630
+24,234
| +12% | +$887K | ﹤0.01% | 1816 |
|
|
2021
Q1 | $7.14M | Sell |
206,396
-2,689
| -1% | -$93K | ﹤0.01% | 1864 |
|
|
2020
Q4 | $8.69M | Buy |
+209,085
| New | +$8.69M | ﹤0.01% | 1792 |
|